FDA Releases Revised Draft Guidance for In Vitro Diagnostic Multivariate Index Assays

Summary

The Food and Drug Administration (FDA) has made available a revised draft guidance document addressing the definition and regulatory status of In Vitro Diagnostic Multivariate Index Assays (IVDMIAs), a class of in vitro diagnostic devices, and their premarket and postmarket requirements.